The deal involving Medicxi was based around six assets and completed at a premium to NAV, co-founder Francesco De Rubertis told Secondaries Investor.
2 min read · 23 September 2020
The $60bn US pension backed the Revelstoke and Accel-KKR GP-led deals last year and expects to invest in more before the year is out.
2 min read · 16 September 2020
An apparent flurry of dealflow doesn’t mean they will all get across the line
2 min read · 10 September 2020
Landmark Partners and NM PERA recently introduced the Excess Value Method, calculating the dollar value of a private investment’s performance against a benchmark. This could change how GPs get compensated, Avi Turetsky explains.
8 min read · 10 September 2020
Secondary market innovations bode well for investors and GPs that need to be nimble in an evolving landscape, write Mozaic Capital’s Solomon Owayda and Christine Patrinos.
4 min read · 02 September 2020
The deal could involve around $100m in follow-on capital, Secondaries Investor has learned.
2 min read · 26 August 2020
The tech investor is considering giving LPs the chance to sell or roll in a deal likely to be worth more than $1bn, Secondaries Investor has learned.
2 min read · 20 August 2020
This year’s health crisis has made single-asset transactions more appealing for a host of reasons.
3 min read · 20 August 2020
High amounts of dry powder, new entrants such as Brookfield Asset Management and a pressing need to extend fund lives could result in the real estate market bouncing back this year.
4 min read · 19 August 2020
